Heidi R. Tucker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Heidi R. Tucker has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Ashley Frazer-Abel
Exsera BioLabs, University of Colorado School of Medicine, 1775 Aurora Court, Mail Stop B115, Aurora, CO 80045, United States
1 shared publication Bradley S. Barrett
University of Colorado Anschutz Medical Campus, Aurora, Colorado
1 shared publication- Gillian Andersen
University of Colorado Anschutz Medical Campus, Aurora, Colorado
1 shared publication - Jennifer L. Yates
Division of Infectious Diseases, Wadsworth Center New York State Department of Health Albany New York USA
1 shared publication - Jessica M. Colón Franco
Department of Laboratory Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA
1 shared publication - Kejun Guo
Division of Infectious Diseases, Department of Medicine, University of Colorado School of Medicine , 12700 E 19th Ave, Mail Stop B168, Aurora, CO 80045
1 shared publication
Latest Publications
- Open Access
- 6 January 2022
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 106 (2) , 562-565
COVID-19 Serology Control Panel Using the Dried-Tube Specimen Method
The dried-tube specimen (DTS) procedure was used to develop the COVID-19 serology control panel (CSCP). The DTS offers the benefit of shipping materials without a cold chain, allowing for greater access without deterioration of material integrity. Samples in the panel were sourced from COVID-19 convalescent persons from March to May 2020. The immunoglobulin subtypes (total Ig, IgM, and IgG) and their respective reactivity to severe acute respiratory syndrome coronavirus 2 nucleocapsid, spike, and receptor-binding domain antigens of the samples were delineated and compared with the WHO International Standard to elucidate the exact binding antibody units of each CSCP sample and ensure the CSCP provides adequate reactivity for different types of serological test platforms. We distribute the CSCP as a kit with five coded tubes to laboratories around the world to be used to compare test kits for external quality assurance, for harmonizing laboratory testing, and for use as training materials for laboratory workers.
- 6 January 2022
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 106 (2) , 562-565
Open AccessCOVID-19 Serology Control Panel Using the Dried-Tube Specimen Method
The dried-tube specimen (DTS) procedure was used to develop the COVID-19 serology control panel (CSCP). The DTS offers the benefit of shipping materials without a cold chain, allowing for greater access without deterioration of material integrity. Samples in the panel were sourced from COVID-19 convalescent persons from March to May 2020. The immunoglobulin subtypes (total Ig, IgM, and IgG) and their respective reactivity to severe acute respiratory syndrome coronavirus 2 nucleocapsid, spike, and receptor-binding domain antigens of the samples were delineated and compared with the WHO International Standard to elucidate the exact binding antibody units of each CSCP sample and ensure the CSCP provides adequate reactivity for different types of serological test platforms. We distribute the CSCP as a kit with five coded tubes to laboratories around the world to be used to compare test kits for external quality assurance, for harmonizing laboratory testing, and for use as training materials for laboratory workers.